Evidence map›Paper›PMID 26431970›Full record

ArticleApplied and environmental microbiology2015

Multiplexed integrating plasmids for engineering of the erythromycin gene cluster for expression in Streptomyces spp. and combinatorial biosynthesis.

Bahgat Fayed, David A Ashford, Amal M Hashem, Magdy A Amin, Omaima N El Gazayerly, Matthew A Gregory, Margaret C M Smith

Open access · hybridAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Current Approaches for Genetic Manipulation ofBiotech (Basel (Switzerland)) · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Recent advances in natural products exploitation inEngineering in life sciences · 2019
    Review
  9. Article
  10. Review
  11. Article
  12. Synthetic Biology of Natural Products.Cold Spring Harbor perspectives in biology · 2016
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Bahgat FayedDepartment of Biology, University of York, York, United Kingdom Chemistry of Natural and Microbial Products Department, National Research Centre, Cairo, Egypt.
David A AshfordBioscience Technology Facility, Department of Biology, University of York, York, United Kingdom.
Amal M HashemChemistry of Natural and Microbial Products Department, National Research Centre, Cairo, Egypt.
Magdy A AminDepartment of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Omaima N El GazayerlyDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Matthew A GregoryIsomerase Therapeutics, Science Village, Chesterford Research Park, Cambridge, United Kingdom.
Margaret C M SmithDepartment of Biology, University of York, York, United Kingdom maggie.smith@york.ac.uk.ORCID http://orcid.org/0000-0002-4150-0496
Cairo University · EGNational Research Centre · EGUniversity of York · GBIsomerase Therapeutics (United Kingdom) · GB

Funding

Biotechnology and Biological Sciences Research Council BB/K003356/1
6 · The paper itself

Abstract

Bacteria in the genus Streptomyces and its close relatives are prolific producers of secondary metabolites with antibiotic activity. Genome sequencing of these bacteria has revealed a rich source of potentially new antibiotic pathways, whose products have never been observed. Moreover, these new pathways can provide novel genes that could be used in combinatorial biosynthesis approaches to generate unnatural analogues of existing antibiotics. We explore here the use of multiple orthologous integrating plasmid systems, based on the int/attP loci from phages TG1, SV1, and ϕBT1, to express the polyketide synthase (PKS) for erythromycin in a heterologous Streptomyces host. Streptomyces strains containing the three polyketide synthase genes eryAI, eryAII, and eryAIII expressed from three different integrated plasmids produced the aglycone intermediate, 6-deoxyerythronolide B (6-dEB). A further pair of integrating plasmids, both derived from the ϕC31 int/attP locus, were constructed carrying a gene cassette for glycosylation of the aglycone intermediates, with or without the tailoring gene, eryF, required for the synthesis of erythronolide B (EB). Liquid chromatography-mass spectrometry of the metabolites indicated the production of angolosaminyl-6-dEB and angolosaminyl-EB. The advantages of using multiplexed integrating plasmids for engineering expression and for combinatorial biosynthesis were demonstrated.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsChromatography, LiquidErythromycinGenetic EngineeringGlycosylationMass SpectrometryMultienzyme ComplexesMultigene FamilyPlasmidsStreptomyces6-deoxyerythronolide BAnti-Bacterial AgentsBacterial ProteinsErythromycinerythronolide BMultienzyme Complexes

Identifiers

PMID26431970
PMCPMC4644662
OpenAlexW2174222541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.